Search Tufts Medicine

Displaying 141 - 160 of 180
Articles
December 12, 2023
We know the idea of needing surgery on your brain or spine can be scary, here’s how to find a neurosurgeon who will get you back to feeling your best.
Articles
December 5, 2019
Influenza (flu) is an unwelcome part of the holiday season, often spreading with the arrival of cold weather and sidelining many people from enjoying festive activities. However, by taking certain precautions we can ward off infections and stay healthy.
Articles
August 12, 2019
Third year Gastroenterology fellow at Tufts Medical Center, Sukeerti Kesar, MD, sprung to action to help Nico Pellegrino as he was having a heart attack.
Patient Stories
August 8, 2019
Nearly 1 year after being attacked by a great white shark, Dr. Lytton returned to Tufts Medical Center to share this story.
clinical trial
...

This research study is a 3-week clinical trial of dronabinol, a synthetic form of tetrahydrocannabinol (THC). This study is being done to determine if dronabinol is a safe and effective treatment for agitation symptoms related to Alzheimer’s disease. This study will compare dronabinol to a placebo.
Patient Stories
January 4, 2019
Phillipe doesn’t like to sit still. An architect at a firm in Boston’s Seaport, he’s used to being on the move – at work, at home and at the gym. In early 2018, he was forced to slow down when a debilitating back injury interfered with his busy life.
clinical trial
...

To demonstrate that remibrutinib is superior to teriflunomide in reducing the frequency of confirmed relapses.
In the News
November 1, 2024
Q&A with Brent Forester, MD, Chair of the Department of Psychiatry at Tufts Medical Center; Interim Chair of the Department of Neurology at Tufts Medical Center; and Director of Behavioral Health for Tufts Medicine, about his new study, which found that synthetic THC may be effective in reducing agitation in people with Alzheimer’s dementia.
clinical trial
...

Transcranial magnetic stimulation (TMS) has proven to be a useful tool to characterize corticospinal drive in awake behaving humans. For example, increased corticospinal drive associated with voluntary contraction results in facilitation of the TMS-elicited motor evoked potential (MEP) relative to the MEP at rest. Given the pathophysiological processes in ALS that disrupt corticospinal drive, quantifying failure of facilitation can be used to detect UMN dysfunction, potentially providing a biomarker at earlier stages of the disease.
clinical trial
...

The purpose of this study is to see if the study drug, elezanumab, is safe and able to improve function in patients with acute traumatic cervical spinal cord injury (SCI).
department
The Department of Neurosurgery performs more than 1,700 procedures a year for patients living with high-risk brain tumors, complex spinal cord injuries and disorders presenting from nearly every branch of medicine. Our hands-on approach to patient care is mirrored in our immersive, seven-year residency program, where we prepare tomorrow’s neurosurgeons.
clinical trial
...

This is an observational study to assess the the burden of neuropathic involvement in wild-type transthyretin amyloidosis
clinical trial
...

This study aims to compare the effects of inhaled isoflurane sedation with the standard of care IV sedative propofol. Patients enrolled on this study will be on a ventilator (breathing machine) for more than 12 hours and require continuous sedation to keep the patient comfortable which can range from a state of drowsiness and relaxtion to a state of unconsciousness.